PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
Analyze analyst forecasts for the company and compare them with competitors.
9.68M
Better than ANVS's estimated revenue of 0.
-1.93M
Worse than ANVS's estimated ebitda of 0.
-1.38
Better than ANVS's estimated eps of -1.87.
-41.62M
Worse than ANVS's estimated net income of -16.86M.
-1.93M
Worse than ANVS's estimated ebit of 0.
358.54M
Worse than ANVS's estimated sg&a expense of 0.
Analyze DCF forecasts for the company and compare them with competitors.
No Data
No DCF data available for this metric in the selected year.
No Data
No DCF data available for this metric in the selected year.
-21.77M
Worse than ANVS's ebitda of 0.00.
100.00%
Equal to ANVS's ebitda margin of 100.00%.
-22.21M
Worse than ANVS's ebit of -6.64M.
100.00%
Equal to ANVS's ebit margin of 100.00%.
447.00K
Better than ANVS's depreciation of 6.64M.
63.56M
Better than ANVS's total cash of 8.07M.
100.00%
Equal to ANVS's cash as percentage of revenue of 100.00%.
No Data
No DCF data available for this metric in the selected year.
100.00%
Equal to ANVS's receivables as percentage of revenue of 100.00%.
No Data
No DCF data available for this metric in the selected year.
100.00%
Equal to ANVS's inventories as percentage of revenue of 100.00%.
4.34M
Worse than ANVS's accounts payable of 341.86K.
100.00%
Equal to ANVS's payables as percentage of revenue of 100.00%.
-253.00K
Better than ANVS's capital expenditure of 0.00.
100.00%
Equal to ANVS's capex as percentage of revenue of 100.00%.
4.99%
Better than ANVS's weighted average cost of capital (wacc) of 12.44%.
5.02%
Better than ANVS's cost of equity of 12.44%.
4.08%
Better than ANVS's cost of debt of 4.40%.
-0.23
Better than ANVS's beta of 1.70.
30.07M
Worse than ANVS's diluted shares outstanding of 9.02M.
1.57M
Worse than ANVS's total debt of 0.00.
49.31M
Better than ANVS's total equity of 42.50M.
50.89M
Better than ANVS's total capital of 42.50M.
3.09%
Worse than ANVS's debt weighting of 0.00%.
96.91%
Worse than ANVS's equity weighting of 100.00%.
-22.04M
Worse than ANVS's ebiat of -5.18M.
-17.50M
Better than ANVS's unlevered free cash flow of -744.34M.
2.00%
Equal to ANVS's long-term growth rate of 2.00%.
No Data
No DCF data available for this metric in the selected year.
No Data
No DCF data available for this metric in the selected year.
-71.33M
Better than ANVS's net debt of -5.75M.
71.33M
Better than ANVS's equity value of 4.60M.
2.37
Better than ANVS's equity value per share of 0.51.
View analysts' price targets and recommendations, and compare them with competitors.
$11.07
Analysts expect the stock price to increase by 521.91%.
Buy
Positive consensus among analysts.